Search results

Technologies 2

• FeCILL: Targeted Treatment for Severe Fungal Infections
  FeCILL is novel delivery vehicle for antifungal drugs that targets them right to the infection site and reduces harmful side effects in patients with severe fungal infections.
• Ovarian Modeling for Fertility Treatments
  Infertility is a global health problem, affecting nearly every industrialized nation in the world, and an estimated 10% of men and women in the US. Ovarian abnormalities and oogenesis disorders are a leading cause of female infertility, but little is known about their underlying genetic causes due to lack of suitable research models. We’re collaborating...

News 5

View all

• Translation News
  
  CRISPR’s Impact, Today
  October 21, 2024
• Translation News
  
  Attivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies
  October 2, 2024
• Translation News
  
  In a first, genetically edited pig kidney is transplanted into human
  March 22, 2024

Multimedia 1

• 

  Video/Animation
  FeCILL: Reimagining How We Treat the Sickest Patients
  Opportunistic fungal infections usually only affect patients whose immune systems are compromised, but when they do, they are often deadly – the mortality rate for these infections can be as high as 25%. Existing antifungal treatments have high levels of toxicity, and can harm the patient more than they help. Researchers at the Wyss Institute...